Susquehanna International Group, LLP Theravance Biopharma, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$8.58 - $11.4 $168,168 - $223,440	-19,600 Reduced 22.9%	66,000 $741,000
Q3 2023 Nov 14, 2023	BUY	$8.38 - $10.44 $579,058 - $721,404	69,100 Added 418.79%	85,600 $738,000
Q2 2023 Aug 11, 2023	SELL	$10.16 - $11.92 $1.17 Million - $1.37 Million	-115,200 Reduced 87.47%	16,500 $170,000
Q1 2023 May 16, 2023	SELL	$9.87 - $11.44 $908,039 - $1.05 Million	-92,000 Reduced 41.13%	131,700 $1.43 Million
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $1.2 Million - $1.41 Million	124,700 Added 125.96%	223,700 $2.51 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $91,451 - $111,398	10,900 Added 12.37%	99,000 $1 Million
Q2 2022 Aug 15, 2022	BUY	$8.41 - $10.34 $201,840 - $248,160	24,000 Added 37.44%	88,100 $798,000
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $432,327 - $672,624	51,900 Added 425.41%	64,100 $613,000
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $1.43 Million - $2.12 Million	-192,200 Reduced 94.03%	12,200 $135,000
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $1.03 Million - $2.19 Million	152,000 Added 290.08%	204,400 $1.51 Million
Q2 2021 Aug 11, 2021	BUY	$14.52 - $22.46 $142,296 - $220,108	9,800 Added 23.0%	52,400 $761,000
Q1 2021 May 17, 2021	BUY	$16.57 - $21.08 $268,434 - $341,496	16,200 Added 61.36%	42,600 $869,000
Q3 2020 Nov 16, 2020	SELL	$14.79 - $22.49 $211,497 - $321,607	-14,300 Reduced 35.14%	26,400 $390,000
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $349,664 - $611,716	19,600 Added 92.89%	40,700 $941,000
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $177,840 - $286,710	11,400 Added 117.53%	21,100 $345,000
Q1 2019 May 15, 2019	BUY	$22.57 - $28.15 $4,514 - $5,630	200 Added 2.11%	9,700 $220,000
Q4 2018 Feb 14, 2019	SELL	$22.52 - $35.07 $45,040 - $70,140	-2,000 Reduced 17.39%	9,500 $243,000
Q3 2018 Nov 14, 2018	BUY	$22.83 - $32.67 $262,545 - $375,705	11,500 New	11,500 $376,000

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$93.8 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$73.5 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$44.4 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$37.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$27.2 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account